IL2RG and colon adenocarcinoma: Extending our scrutiny to a comparative transcriptomic assay, containing 275 COAD patients and 349 non-pathological controls drawn from the TCGA and GTEx repositories further underscored the conspicuous hyperexpression of the IL-2RG gene (Fig. 1B).